Respiratory function and inspiratory muscle training for adults with obesity

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with obesity will be enrolled at a single center and randomly assigned to receive inspiratory muscle training or a placebo IMT protocol. Respiratory mechanics will be measured using techniques such as the forced oscillation technique, and inflammatory markers will be tracked to link breathing changes with inflammation. Participants with active respiratory disease requiring medication or other major medical exclusions are not eligible. The protocol focuses on supervised, repeated IMT sessions compared with a sham device to determine functional and inflammatory effects.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* diagnosed obesity, BMI equal to or greater than 30 kg/m2
* age between 30 and 60 (women and men),
* consent of the subject.

Exclusion Criteria:

* respiratory diseases requiring pharmacological treatment,
* acute illness that may affect the training programme: e.g. infection, renal failure,
* mental impairment preventing cooperation,
* mental disorders preventing contact and cooperation with the patient,
* pacemaker,
* pregnancy
* implanted electronic
* medical implants
* epilepsy
* metal implants.

Where it's running

• Wroclaw University of Health and Sport Sciences
  Wroclaw, Dolny Śląsk, Poland Recruiting

Study contacts

• Principal investigator: Dariusz Kałka, prof. — Wroclaw University of Health and Sport Sciences
• Study coordinator: Paulina Okrzymowska, phD
• Email: paulina.okrzymowska@awf.wroc.pl
• Phone: +48 71 347 3520

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• How incretin treatments affect muscle mass and function in people with overweight or obesity

  This study will see how drugs like semaglutide and tirzepatide influence fat-free mass, muscle strength, and physical function in adults with overweight or obesity.

  Recruiting Radboud University Medical Center · Amsterdam and 1 other locations · NCT07929831

• Dose find for remimazolam plus alfentanil for gastroscopy in obese adults

  This trial tests what dose of remimazolam besylate with alfentanil best sedates obese adults during gastroscopy.

  Recruiting Qianfoshan Hospital · Jinan, Shandong · NCT07925684

• Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults

  This study compares how much weight adults lose over two years when starting GLP-1 medicines versus adults who had sleeve gastrectomy at the same center.

  Recruiting Yuzuncu Yil University · Van · NCT07901777

• Gut barrier and inflammation after fast-food overfeeding in adults

  This study tests whether 14 days of fast-food overfeeding can alter gut barrier function and trigger inflammation in adults who are generally healthy.

  Recruiting University Hospital, Gentofte, Copenhagen · Hellerup · NCT07893743

• High BMI and periodontitis in Thai adults under 60

  This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.

  Recruiting Mahidol University · Bangkok, Ratchathewi · NCT07880717

• GLP-1 weight‑loss medicine: finding who will benefit most

  This study tests whether a GLP-1 drug called semaglutide helps with weight loss by changing eating behavior, to see which people it helps the most.

  Recruiting Phase 4 Universitaire Ziekenhuizen KU Leuven · Leuven · NCT07870538

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.